Stereotaxis (NYSEAMERICAN:STXS) Trading 4.4% Higher

Stereotaxis, Inc. (NYSEAMERICAN:STXS) rose 4.4% during mid-day trading on Thursday . The stock traded as high as $2.68 and last traded at $2.62. Approximately 214,107 shares changed hands during trading, a decline of 19% from the average daily volume of 264,972 shares. The stock had previously closed at $2.51.

Analyst Upgrades and Downgrades

STXS has been the subject of several research reports. Lake Street Capital upped their price objective on shares of Stereotaxis from $3.00 to $4.00 and gave the company a “buy” rating in a research note on Tuesday, March 5th. Roth Mkm reiterated a “buy” rating and issued a $5.00 target price on shares of Stereotaxis in a report on Tuesday, March 5th.

Stereotaxis Stock Performance

The company has a market capitalization of $215.18 million, a price-to-earnings ratio of -9.36 and a beta of 1.35.

Stereotaxis (NYSEAMERICAN:STXS) last announced its earnings results on Monday, March 4th. The company reported ($0.07) earnings per share for the quarter, hitting the consensus estimate of ($0.07). Stereotaxis had a negative net margin of 77.37% and a negative return on equity of 103.37%. The firm had revenue of $4.57 million for the quarter, compared to the consensus estimate of $7.55 million. As a group, analysts predict that Stereotaxis, Inc. will post -0.23 EPS for the current year.

Institutional Trading of Stereotaxis

Several hedge funds have recently made changes to their positions in STXS. Geode Capital Management LLC grew its holdings in shares of Stereotaxis by 1.1% during the fourth quarter. Geode Capital Management LLC now owns 444,787 shares of the company’s stock worth $920,000 after buying an additional 4,917 shares in the last quarter. Vanguard Group Inc. lifted its position in shares of Stereotaxis by 0.4% during the third quarter. Vanguard Group Inc. now owns 2,183,230 shares of the company’s stock worth $3,450,000 after purchasing an additional 7,646 shares in the last quarter. Silverarc Capital Management LLC lifted its position in shares of Stereotaxis by 2.5% during the fourth quarter. Silverarc Capital Management LLC now owns 354,925 shares of the company’s stock worth $735,000 after purchasing an additional 8,694 shares in the last quarter. Wealth Effects LLC lifted its position in shares of Stereotaxis by 16.0% during the third quarter. Wealth Effects LLC now owns 69,060 shares of the company’s stock worth $109,000 after purchasing an additional 9,500 shares in the last quarter. Finally, Independent Advisor Alliance lifted its position in shares of Stereotaxis by 11.0% during the third quarter. Independent Advisor Alliance now owns 101,305 shares of the company’s stock worth $160,000 after purchasing an additional 10,000 shares in the last quarter. Institutional investors and hedge funds own 45.35% of the company’s stock.

About Stereotaxis

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.